Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Geographic atrophy (GA), is an advanced form of age-related macular degeneration (AMD), affecting the retina, a part of the eye that sends information to the brain to enable sight. Many people with AMD do not immediately recognise the symptoms, mistaking…

The U.S. Food and Drug Administration (FDA) is warning consumers against the purchase and use of South Moon, Rebright, or FivFivGo eye drops due to the potential risk of eye infection. These products, identified as copycats, pose a danger as…

The launch of “ Enova – C Haptic Model IOL” has recently been announced by VSY Biotechnology GmbH. Enova, the first and only 100% glistening-free, dry-packed hydrophobic acrylic IOL, requires no warming or special conditioning before surgery. The lens requires…

A team of investigators, led by Elizabeth Yeu, MD, from Virginia Eye Consultants in Norfolk, Virginia, reported the safety and efficacy of lotilaner ophthalmic solution, 0.25% (TP-03, Tarsus Pharmaceuticals Inc.), in treating Demodex blepharitis. Demodex mites are the most common…

Azalea Vision announced the successful demonstration of the ALMA Lens, marking the debut of the first functional prototype for the Azalea smart contact lens platform. The ALMA proprietary device is designed to provide a non-surgical solution for individuals dealing with…

Dry eye disease is more common in people over the age of 50. Hormonal changes, especially common in women, can cause dry eye. Other medical conditions including diabetes, glaucoma, Sjogren’s syndrome, lupus, and rheumatoid arthritis can exacerbate dry eye symptoms.…

Imagine you wake up one morning, and everything seems a little blurry. At first, you think it’s just a sleepy haze, but your vision doesn’t clear up as the day goes on. You visit the eye doctor, and after a…

Our eyes are intricate organs that are exposed to various environmental factors and oxidative stress throughout our lives. The presence of highly reactive molecules called free radicals can damage the cells and tissues in our eyes, leading to vision problems…

In a significant stride towards combating global corneal blindness, the Australian Government’s Medical Research Futures Fund (MRFF) has allocated a substantial sum of $35 million to BIENCO, a consortium comprising clinical, scientific, and governance experts. The University of Wollongong (UOW)…

Swiss-based pharmaceutical company Roche has announced the discontinuation of its oral diabetic retinopathy treatment, vicasinabin, after successfully completing Phase II clinical trials. In a recent presentation to investors, Roche confirmed its decision to halt further investment in vicasinabin, a promising…